Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel B Mark

Showing results (81-90 of 331) with videos related to

Pageof 34
Sort By:
American Heart Journal|December 17, 2011
Design of the Trial to Assess Chelation Therapy (TACT)Gervasio A Lamas, Christine Goertz, Robin Boineau, et al.
The American Journal of Medicine|February 3, 2009
Do income level and race influence survival in patients receiving hemodialysis?Eric L Eisenstein, Jie L Sun, Kevin J Anstrom, et al.
Health Policy (Amsterdam, Netherlands)|May 27, 2008
Re-evaluating the volume-outcome relationship in hemodialysis patientsEric L Eisenstein, Jie L Sun, Kevin J Anstrom, et al.
American Heart Journal|April 25, 2007
Absence of bilateral vision loss from amiodarone: a randomized trialJoel S Mindel, Jill Anderson, Anne Hellkamp, et al.
Journal of the American College of Cardiology|September 3, 2013
Reply: rapid rate nonsustained ventricular tachycardia found on ICD interrogation: relationship of RR-NSVT to outcomes in the SCD-HeFT trialJay Chen, George Johnson, Anne S Hellkamp, et al.
American Heart Journal|February 22, 2003
Development and validation of a simple model to predict severe coronary artery disease after myocardial infarction: potential impact on cardiac catheterization use in the United States and CanadaWayne B Batchelor, Daniel B Mark, J David Knight, et al.
Psychosomatic Medicine|September 24, 2004
Hostility as a predictor of survival in patients with coronary artery diseaseStephen H Boyle, Redford B Williams, Daniel B Mark, et al.
American Heart Journal|July 2, 2005
Economic analysis of the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT-3) study: costs of reperfusion strategies in acute myocardial infarctionPadma Kaul, Paul W Armstrong, Patricia A Cowper, et al.
Journal of the American College of Cardiology|June 12, 2003
Poverty, process of care, and outcome in acute coronary syndromesSunil V Rao, Padma Kaul, L Kristin Newby, et al.
JACC. Clinical Electrophysiology|May 25, 2019
Patient-Reported Outcomes in Atrial Fibrillation Research: Results of a Clinicaltrials.gov AnalysisBenjamin A Steinberg, Paul Dorian, Kevin J Anstrom, et al.
Pageof 34

Showing results (81-90 of 331) with videos related to

Sort By:
Pageof 34
American Heart Journal|December 17, 2011
Design of the Trial to Assess Chelation Therapy (TACT)Gervasio A Lamas, Christine Goertz, Robin Boineau, et al.
The American Journal of Medicine|February 3, 2009
Do income level and race influence survival in patients receiving hemodialysis?Eric L Eisenstein, Jie L Sun, Kevin J Anstrom, et al.
Health Policy (Amsterdam, Netherlands)|May 27, 2008
Re-evaluating the volume-outcome relationship in hemodialysis patientsEric L Eisenstein, Jie L Sun, Kevin J Anstrom, et al.
American Heart Journal|April 25, 2007
Absence of bilateral vision loss from amiodarone: a randomized trialJoel S Mindel, Jill Anderson, Anne Hellkamp, et al.
Journal of the American College of Cardiology|September 3, 2013
Reply: rapid rate nonsustained ventricular tachycardia found on ICD interrogation: relationship of RR-NSVT to outcomes in the SCD-HeFT trialJay Chen, George Johnson, Anne S Hellkamp, et al.
American Heart Journal|February 22, 2003
Development and validation of a simple model to predict severe coronary artery disease after myocardial infarction: potential impact on cardiac catheterization use in the United States and CanadaWayne B Batchelor, Daniel B Mark, J David Knight, et al.
Psychosomatic Medicine|September 24, 2004
Hostility as a predictor of survival in patients with coronary artery diseaseStephen H Boyle, Redford B Williams, Daniel B Mark, et al.
American Heart Journal|July 2, 2005
Economic analysis of the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT-3) study: costs of reperfusion strategies in acute myocardial infarctionPadma Kaul, Paul W Armstrong, Patricia A Cowper, et al.
Journal of the American College of Cardiology|June 12, 2003
Poverty, process of care, and outcome in acute coronary syndromesSunil V Rao, Padma Kaul, L Kristin Newby, et al.
JACC. Clinical Electrophysiology|May 25, 2019
Patient-Reported Outcomes in Atrial Fibrillation Research: Results of a Clinicaltrials.gov AnalysisBenjamin A Steinberg, Paul Dorian, Kevin J Anstrom, et al.
Pageof 34